Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The North America colorectal cancer screening tests market size was valued at USD 6.27 Billion in 2025. The market is further projected to grow at a CAGR of 5.60% between 2026-2035, reaching a value of USD 10.81 Billion by 2035.
Base Year
Historical Period
Forecast Period
The American Cancer Society's estimates for colorectal cancers in the United States of America for 2024 are around 106,590 new cases of colon cancer and 46,220 new cases of rectal cancer.
As per industry reports, in 2021, approximately 24,800 cases of colorectal cancer had been diagnosed in Canada.
According to the Canadian Cancer Society, colorectal cancer is the fourth most common cancer in the country.
Compound Annual Growth Rate
5.6%
Value in USD Billion
2026-2035
*this image is indicative*
According to the North America colorectal cancer screening tests market report, a rising number of younger people are being diagnosed with colorectal cancer in North America. Factors contributing to an increase in colorectal cancer are an unhealthy diet, lack of physical activity, and a rise in smoking and alcohol consumption as well as genetics or family history. Symptoms of colorectal cancer include blood in stool, changes in bowel habits, and unexplained weight loss. Canadian provinces conduct routine colorectal cancer screening programs, which aids the market growth.
According to the North America colorectal cancer screening tests market analysis, the fecal immunochemical test (FIT) is an easy-to-use stool test that can also be done at home. It can help patients find colorectal cancer early, as well as precancerous conditions that if untreated might become colorectal cancer. In Canada, Ontario, and British Columbia recommend FIT screening every two years, while people living in Alberta are eligible for annual FIT screening. The U.S. Preventive Services Task Force recommends that adults aged between 45 to 75 be regularly screened for colorectal cancer. The colorectal cancer survival rate is rising in Canada and the United States supported by earlier detection of the cancer through routine examinations and screening and due to advances in treatments.
North America Colorectal Cancer Screening Tests Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments.
Market Breakup by Screening Tests
Market Breakup by End User
Market Breakup by Region
The key players in the colorectal cancer screening tests market in North America are producing highly efficient colorectal cancer screening tests.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2025, the North America colorectal cancer screening tests market reached an approximate value of USD 6.27 Billion.
The market is expected to grow at a CAGR of 5.60% between 2026 and 2035.
The market is estimated to witness healthy growth in the forecast period of 2026-2035 to reach USD 10.81 Billion by 2035.
A colonoscopy is one of the most sensitive tests available for colon cancer screening. The doctor views the patient’s entire colon and rectum and removes abnormal tissue, such as polyps during the exam.
Stool-based tests look at the stool for possible signs of colorectal cancer or polyps.
The major drivers of the market include rising occurrences of colorectal cancer in young patients, advancement in screening technology, and rising awareness of colorectal cancer.
Key trends aiding market expansion include rising emphasis on colorectal cancer screening, the availability of screening kits, and extensive research to enhance the quality and efficiency of colorectal cancer screening kits.
Major regions in the market are the United States of America and Canada.
The end user of colorectal cancer screening tests are hospitals, diagnostic centres/ laboratories, and others.
Key players in the market are Abbott Laboratories, 3T Medical Complete Systems, Epigenomics AG, Exact Sciences Corporation, Roche Diagnostics Corporation, Siemens AG, Sysmex Inostics, Inc., EKF Diagnostics Holdings Plc, Laboratory Corporation of America® Holdings., and LetsGetChecked Inc, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Screening Tests |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share